VEGF and depression: a comprehensive assessment of clinical data.
about
Protein biomarkers of mood disorders.Anhedonic behavior in cryptochrome 2-deficient mice is paralleled by altered diurnal patterns of amygdala gene expression.VEGF-related polymorphisms identified by GWAS and risk for major depression.The effect of depression on serum VEGF level in Alzheimer's disease.Pathogenesis of depression: Insights from human and rodent studies.Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.Neurobiology of major depressive disorderIncreased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF.A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior.Towards a multi protein and mRNA expression of biological predictive and distinguish model for post stroke depression.Alterations in VEGF expression induced by antidepressant drugs in female rats under chronic social stress.Angiogenesis inhibition and depression in older menInflammation and vascular remodeling in the ventral hippocampus contributes to vulnerability to stress.Vascular endothelial growth factor: Potential predictor of treatment response in major depression.How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms.Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder.Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression.Prevalence and risk factors for depression in newly diagnosed patients with POEMS syndrome.Exploration of 27 plasma immune markers: a cross-sectional comparison of 64 old psychiatric inpatients having unipolar major depression and 18 non-depressed old persons.Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to PrecisionNeurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
P2860
Q30395834-7D6FC68C-22A0-48F1-A0DF-486F823F29B8Q30653524-0C1C74E0-67FF-4FD7-888A-3A55CC269D2FQ33635586-50F0B730-ABCE-48DA-89F3-A49DE73C645EQ35206889-123C3776-0C42-49B0-88A3-8A3C1BD868EFQ36332597-7DB07304-F762-44DD-AB79-71E896BFABB8Q36813765-CE65E2FF-AF68-4989-824F-912C10758C20Q37260128-43C681C3-021F-4F15-98B0-74EBB515A67DQ37347646-3F670E0D-E551-4116-8437-B9AAA15F6006Q37405727-1650CD1F-1A8B-4965-97B0-2E140056EAF7Q37424483-C101CA51-D754-4E4B-8261-F3EF4302A206Q37688061-D4CE72B0-69B1-4F2A-8FE8-5AA8CAA51E21Q37697728-C6F94F0D-B295-4291-9EE7-D0843777ECA1Q37719823-A9C41DAC-44A5-499A-9A9A-5AC46B9D64C4Q39308821-D6402573-C116-4D35-B816-414721387E96Q40149264-004D280C-62F7-47F4-AC38-0F9B662315D7Q41474658-CCE76CC3-FA9D-4549-91CD-E20D206D7E73Q47555578-EF69E81B-52C3-4B7A-BB6E-1F9795FA8073Q47750361-54DACE3A-FAC6-492B-8ED2-A4AF035728BEQ48352580-3FAD31F4-F2C3-4C3E-A423-2A4D3751845BQ55499462-BD1B8CB2-49A1-4098-9DC8-518B4D87520AQ57167792-F3D039EA-71D0-42BE-85C7-EABDE9A0A44CQ57173547-1C49A21A-D8D2-44ED-AB11-586727314698
P2860
VEGF and depression: a comprehensive assessment of clinical data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
VEGF and depression: a comprehensive assessment of clinical data.
@ast
VEGF and depression: a comprehensive assessment of clinical data.
@en
type
label
VEGF and depression: a comprehensive assessment of clinical data.
@ast
VEGF and depression: a comprehensive assessment of clinical data.
@en
prefLabel
VEGF and depression: a comprehensive assessment of clinical data.
@ast
VEGF and depression: a comprehensive assessment of clinical data.
@en
P1476
VEGF and depression: a comprehensive assessment of clinical data.
@en
P2093
Angelos Halaris
Anne Clark-Raymond
P304
P356
10.1016/J.JPSYCHIRES.2013.04.008
P577
2013-05-17T00:00:00Z